Back to search

Ireland· IE-PA-EU/1/07/412/023-24

Abseamed 30 000 IU/0.75 mL solution for injection in a pre-filled syringe

A erythropoietin product containing epoetin alfa, registered in Ireland by Medice Arzneimittel Putter GmbH & Co. K.G. The same ATC class is registered in 12 of our 19 countries.

ATC B03XA01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedAbseamed 30 000 IU/0.75 mL solution f…ATCB03XA01REGISTER NO.IE-PA-EU/1/07/412/023…PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Erythropoietin is registered in 12 of 19 countries.

Countries holding a registration under ATC B03XA01 (erythropoietin), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 8 of them publish a price we can compare per daily dose

Erythropoietin · ATC B03XA01

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
Epoetin alfa
Manufacturer
Medice Arzneimittel Putter GmbH & Co. K.G
Country
Ireland (IE)
ATC code
B03XA01
ATC class
Erythropoietin
Defined daily dose
1 TSD, E
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    EU/1/07/412/023-24

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

18 interactions on record for erythropoietin.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Erythropoietin · interactions on record

18 records

  • 5 severe
  • 3 moderate
  • 10 minor

Most severe, free to view

  • CarfilzomibL01XG02severe
  • CarfilzomibL01XX45severe
  • ThalidomideL04AX02severe
  • LenalidomideL04AX04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Erythropoietin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All erythropoietin products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Erypo
  • Belgium · Eprex
  • Czechia · Eprex
  • Germany · Erypo Fs
  • Spain · Eprex
  • France · Eprex
  • United Kingdom (Northern Ireland) · Eprex
  • Greece · Eprex
  • Iceland · Abseamed, Binocrit
  • Italy · Eprex
  • Liechtenstein · Binocrit, Epoetin Alfa Hexal
  • Luxembourg · Eprex
  • Netherlands · Eprex
  • Norway · Abseamed, Binocrit
  • Portugal · Eprex
  • Slovenia · Eprex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eef70e84-f118-4d34-81f7-805397941ecf
GET /v1/drugs/eef70e84-f118-4d34-81f7-805397941ecf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in pre-filled syringe",
  "routes": [
    "Intravenous use",
    "Subcutaneous use"
  ],
  "source": "hpra",
  "atc_all": [
    "B03XA",
    "B03XA01"
  ],
  "strength": null,
  "pa_number": "EU/1/07/412/023-24",
  "substances": [
    "Epoetin alfa"
  ],
  "legal_basis": "Well-established use application (Article 10a of Directive No 2001/83/EC)",
  "market_info": "Unknown",
  "authorised_at": "26/11/2009",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about erythropoietin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.